CD8A and nasopharyngeal carcinoma: Whereas, EBV positive NPC contains significantly more CD3, CD4 and CD8 tumor infiltrating lymphocytes compared with EBV negative NPC; EBV positive patients with coexpression of CD8 and PDL1 showed better disease free survival and overall survival 133.